Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT02250651 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

528

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: Bimatoprost SR
OTHER: Sham: Applicator Without Needle
DRUG: Active Comparator: Timolol 0.5%
DRUG: Timolol Vehicle (placebo)

Sponsor

Allergan